2022 was another big year for Shockwave and Q4 was no exception! On Twitter, the first Shockwave L6 cases were posted by physicians who participated in its limited release and it was great to see their excitement for our new large-vessel peripheral IVL catheter launching soon in the U.S.! At VIVA ‘22, Dr. Ehrin Armstrong presented the final 1,373 patient cohort data from the Disrupt PAD III Observational Study; this larger patient data set reinforces the predictability of Shockwave IVL and its ability to consistently modify calcium across vessel beds, challenging lesions and complex patients. Additionally, international calcium experts shared their real-world experiences with the safety and efficacy of coronary IVL across different calcium morphologies, including concentric, eccentric and nodular calcium. Check out that and more in the new PulsePoint Newsletter!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
Coronary Clinical Data,
Peripheral Conferences,
Peripheral Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave S4,
PulsePoint Newsletter,
Calcium Corner,
Shockwave M5 & Shockwave M5+,
Reimbursement,
Treating Different Ca++ Morphologies,
Female vs. Male Outcomes,
Empower CAD
It was smooth sailing for Shockwave this summer! Thank you to everyone who made Q3 unforgettable; but before we get cozy for the holidays, let’s reflect on the events that made the quarter one to remember. This year’s TCT was particularly momentous, as we announced the first prospective, female-only study of coronary interventions, EMPOWER CAD. We also explored tips and tricks for IVL with guide extension catheter usage with Dr. Stephan Heo and debated different approaches to modifying nodular calcium with an expert panel. Read up on the latest Shockwave IVL peer-written publications and more in the Q3 PulsePoint Newsletter.
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
Coronary Clinical Data,
Peripheral Conferences,
Peripheral Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave S4,
PulsePoint Newsletter,
Calcium Corner,
Shockwave M5 & Shockwave M5+,
Female vs. Male Outcomes,
Empower CAD
Dr. Jaikirshan J. Khatri, MD, FACC, FSCAI Director of Complex Coronary Intervention Heart, Vascular & Thoracic Institute, at Cleveland Clinic; Cleveland, Ohio shares his calcium modification approach with Coronary IVL including his best practices for pulse management as well as how calcium is affected by the fractures caused by coronary IVL.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. Suzanne J. Baron of Lahey Hospital and Medical Center, Burlington, Massachusetts talks about gender disparities of PCI outcomes in calcified lesions, citing the recent SCAI Expert Consensus Statement, which brings to light the under-representation of women in cardiovascular clinical trials. Dr. Baron also talks about the impact of IVL to improve outcomes in women with calcified disease based on the recently published sex specific analysis of Disrupt CAD Pooled data at SCAI 2022.
For more information on Coronary IVL CAD Pooled Gender Analysis data, please visit ItsTimeForAnIntervention.com
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. Stephan Heo of the New England Heart and Vascular Institute, Catholic Medical Center, Manchester, New Hampshire shares his decision-making process in approaching calcified lesions in complex PCI as well as strategies to deliver IVL with different GEC techniques when facing challenging vessel anatomy and calcium morphology.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. Kevin Croce, Director of Chronic Total Occlusion (CTO)/Complex PCI Program, Interventional Cardiologist, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston Massachusetts talks about the importance of image guided plaque modification in optimizing PCI, discusses the role of IVL in calcium modification and share his insights on Coronary IVL in different calcium morphologies.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. B. Clay Sizemore, Interventional Cardiologist at Cardiovascular Consultants of South Georgia, Thomasville, GA speaks about his experience with coronary IVL in a no surgical backup hospital, discussing his patient selection criteria, importance of same day discharge and how IVL fits well into this strategy, thereby allowing the treatment of previously undilatable calcified lesions and minimizing the risk of patient transfer and procedure staging.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. Margaret McEntegart, Consultant Interventional Cardiologist at West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital and Honorary Associate Clinical Professor, University of Glasgow, Glasgow, United Kingdom speaks about her experience with coronary IVL including practice-changing findings from her research comparing costs and resource utilization of rotational atherectomy vs. coronary Intravascular Lithotripsy.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. Srinivasa Potluri, Chair of the Department of Cardiology and Director of the Cardiac Catheterization Laboratory at Baylor Scott and White, The Heart Hospital in Plano, speaks about his valuable experience with coronary IVL. Dr. Potluri also shares a clinical case with severe ostial RCA and the value of coronary IVL in vessel preparation strategy in the presence of a heavy coronary calcium burden.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Dr. Andrew Klein, Staff Interventional Cardiologist at Piedmont Heart and Vascular Institute in Atlanta shares his valuable experience with coronary IVL. Dr. Klein speaks about his approach to different types of calcific lesions including use of coronary IVL, sharing his best tips and tricks with the technology when used as a stand alone therapy and in combination with other calcium modification tools.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
